Page last updated: 2024-08-17

sodium citrate, anhydrous and Autoimmune Thrombocytopenia

sodium citrate, anhydrous has been researched along with Autoimmune Thrombocytopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gauer, RL; Whitaker, DJ1
Nowak, G1

Trials

1 trial(s) available for sodium citrate, anhydrous and Autoimmune Thrombocytopenia

ArticleYear
Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
    Thrombosis and haemostasis, 2009, Volume: 102, Issue:5

    Topics: Adult; Aged; Anticoagulants; Autoantibodies; Citrates; Early Diagnosis; Female; Heart Diseases; Heparin; Humans; Immunoglobulin G; Kidney Failure, Chronic; Male; Models, Immunological; Platelet Adhesiveness; Platelet Count; Platelet Factor 4; Purpura, Thrombocytopenic, Idiopathic; Receptors, IgG; Renal Dialysis; Sodium Citrate; Stroke

2009

Other Studies

1 other study(ies) available for sodium citrate, anhydrous and Autoimmune Thrombocytopenia

ArticleYear
Thrombocytopenia: Evaluation and Management.
    American family physician, 2022, Volume: 106, Issue:3

    Topics: Hemorrhage; Heparin; Humans; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Sodium Citrate; Thrombotic Microangiopathies

2022